🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The efficacy and safety of Telmisartan capsule in patients with essential h...
Status
Completed
Location
Multiple Locations
Start Date
1998-09
Trial ID
NCT02177448
To determine whether treatment with sacubitril/valsartan provides a superio...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-08-17
Trial ID
NCT02874794
Treatments Being Tested
MAIN OBJECTIVE. Demonstration that use of sacubitril/valsartan influences p...
Status
Unknown
Location
Medical University of Bialystok Clinical Hospital
Start Date
2022-12-13
Trial ID
NCT05487261
Treatments Being Tested
The investigators would like to find out if sitagliptin (dipeptidyl peptida...
Status
Completed
Location
Vanderbilt University- General Clinic Research Center
Start Date
2011-11
Trial ID
NCT01413542
The purpose of this extension study is to compare the long-term safety of v...
Status
Completed
Location
Sites in USA
Start Date
2007-06
Trial ID
NCT00446511
Treatments Being Tested
The purpose of this study was to investigate the effects of initiation of s...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-12-16
Trial ID
NCT02970669
The purpose of the study was to determine the effect of LCZ696 vs. enalapri...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-07-12
Trial ID
NCT02768298
Treatments Being Tested
The purpose of this study was to determine the effect of sacubitril/valsart...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-04-16
Trial ID
NCT03917459
Treatments Being Tested
Chronic allograft nephropathy (CAN) is the leading cause of longterm renal ...
Status
Completed
Location
Montefiore Medical Center
Start Date
2004-09
Trial ID
NCT00270153
The purpose of this study was to assess the effect of in-hospital initiatio...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-04-29
Trial ID
NCT02554890